Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Apr 30, 2026 8:30 am EDT

OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

Apr 30, 2026 8:00 am EDT

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

Apr 28, 2026 4:05 pm EDT

OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results

Apr 22, 2026 8:00 am EDT

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

Apr 21, 2026 4:05 pm EDT

OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026

Apr 8, 2026 8:00 am EDT

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

Feb 27, 2026 8:00 am EST

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

Feb 26, 2026 4:05 pm EST

OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results

Feb 12, 2026 8:00 am EST

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26

Feb 4, 2026 8:00 am EST

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism